Farther Finance Advisors, LLC Xeris Biopharma Holdings, Inc. Transaction History
Farther Finance Advisors, LLC
- $6.63 Trillion
- Q3 2025
A detailed history of Farther Finance Advisors, LLC transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 2,381 shares of XERS stock, worth $17,262. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,381
Previous 181
1215.47%
Holding current value
$17,262
Previous $845,000
2193.61%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding XERS
# of Institutions
237Shares Held
94.1MCall Options Held
251KPut Options Held
61.8K-
Black Rock Inc. New York, NY10.3MShares$74.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.83MShares$71.3 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.84MShares$42.3 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA4.14MShares$30 Million0.0% of portfolio
-
State Street Corp Boston, MA3.74MShares$27.1 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $986M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...